|
Market Closed -
Bombay S.E.
06:02:33 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 159.95 INR | -0.56% |
|
+1.62% | -5.97% |
| Market Cap | 508M 5.31M 4.66M 4.38M 4M 7.48M 7.54M 52.59M 20.39M 259M 19.93M 19.49M 840M | P/E 2025 |
17.4x | P/E 2026 | 5.8x |
|---|---|---|---|---|---|
| Enterprise Value | 476M 4.97M 4.36M 4.1M 3.75M 7M 7.06M 49.24M 19.09M 243M 18.66M 18.25M 787M | EV / Sales 2025 |
2.05x | EV / Sales 2026 | 0.85x |
| Free-Float |
33% | Yield 2025 |
0.87% | Yield 2026 | 1.89% |
| 1 day | -0.56% | ||
| 1 week | +1.62% | ||
| Current month | +2.53% | ||
| 1 month | +4.20% | ||
| 3 months | -8.02% | ||
| 6 months | +41.49% | ||
| Current year | -5.97% |
| 1 week | 144 |  | 164.95 |
| 1 month | 143.05 | | 164.95 |
| Current year | 100.1 | | 188 |
| 1 year | 100.1 | | 220 |
| 3 years | 100.1 | | 398 |
| 5 years | 97.4 | | 398 |
| 10 years | 21.5 | | 398 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rajesh Pokerna
CEO | Chief Executive Officer | 61 | 2016-08-20 |
Sunil Kumar Jain
DFI | Director of Finance/CFO | 64 | 2005-10-06 |
| Compliance Officer | - | 2020-08-02 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 59 | 2005-12-11 | |
Sunil Kumar Jain
BRD | Director/Board Member | 64 | 2005-10-06 |
Rajesh Pokerna
BRD | Director/Board Member | 61 | 2016-08-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.56% | +1.62% | -13.66% | -15.46% | 5.34M | |
| +3.40% | +2.94% | +59.91% | +114.80% | 1,026B | |
| +1.64% | +1.32% | +54.95% | +70.83% | 649B | |
| +0.51% | +0.63% | +20.77% | +71.79% | 468B | |
| +0.37% | +0.83% | +40.13% | +45.94% | 352B | |
| +1.61% | +2.90% | +22.03% | +29.06% | 271B | |
| +0.19% | +0.40% | +11.31% | +11.47% | 256B | |
| +0.53% | +7.30% | +45.94% | +52.70% | 220B | |
| +0.73% | +0.79% | +33.79% | +103.23% | 188B | |
| +0.31% | -9.45% | -31.92% | -60.30% | 170B | |
| Average | +0.90% | +1.78% | +24.33% | +42.41% | 359.91B | |
| Weighted average by Cap. | +1.60% | +1.26% | +39.13% | +68.08% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 340M 3.55M 3.11M 2.93M 2.68M 5M 5.04M 35.16M 13.63M 173M 13.33M 13.03M 562M | 357M 3.73M 3.27M 3.08M 2.81M 5.26M 5.3M 36.96M 14.33M 182M 14M 13.7M 591M |
| Net income | 42.46M 443K 389K 366K 334K 625K 629K 4.39M 1.7M 21.65M 1.66M 1.63M 70.19M | 57.89M 604K 530K 499K 456K 852K 858K 5.99M 2.32M 29.51M 2.27M 2.22M 95.69M |
| Net Debt | -36.87M -385K -338K -318K -290K -543K -547K -3.81M -1.48M -18.8M -1.45M -1.41M -60.95M | -32.39M -338K -297K -279K -255K -477K -480K -3.35M -1.3M -16.52M -1.27M -1.24M -53.55M |
Employees
42
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-24 | ₹159.95 | -0.56% | 305 |
| 26-09-23 | ₹160.85 | +0.53% | 507 |
| 26-09-22 | ₹160.00 | +3.46% | 653 |
| 26-09-21 | ₹154.65 | -1.59% | 1,996 |
| 26-09-18 | ₹157.15 | -0.16% | 2,583 |
- Stock Market
- Stocks
- VRL6 Stock
Select your edition
All financial news and data tailored to specific country editions
